Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Weight Loss Jab Side Effects: What Happens When You Stop - News Directory 3

Weight Loss Jab Side Effects: What Happens When You Stop

September 22, 2025 Jennifer Chen Health
News Context
At a glance
  • A growing number⁢ of people⁢ in the UK are using weight loss medications, but rising costs and concerns about long-term⁣ effectiveness are creating a challenging situation for many.
  • Weight loss jabs, specifically glucagon-like peptide-1 (GLP-1)⁢ receptor agonists such as Wegovy and Ozempic,⁣ have emerged as a transformative tool for many struggling with obesity.
Original source: theguardian.com

“`html

The Weight ⁢Loss Jab Dilemma: Cost, Rebound⁤ Weight Gain, and Access ⁣in the UK

A growing number⁢ of people⁢ in the UK are using weight loss medications, but rising costs and concerns about long-term⁣ effectiveness are creating a challenging situation for many.

May 3, 2024

At a Glance

  • What: Increasing use ‍of weight loss jabs (primarily GLP-1 receptor agonists like Wegovy and Ozempic)⁤ in the UK.
  • Where: United⁣ Kingdom, with ⁤a important portion of prescriptions originating from private providers.
  • When: Rapid growth in⁤ usage over the past two years, with current estimates of 1.5 million users.
  • Why it Matters: These medications offer significant weight loss potential but are expensive and often lead to weight regain when discontinued. Access⁢ is unevenly distributed.
  • What’s Next: Debate continues regarding NHS funding, long-term health impacts, and strategies to mitigate rebound weight gain.

The⁢ Revolution in Weight Loss

Weight loss jabs, specifically glucagon-like peptide-1 (GLP-1)⁢ receptor agonists such as Wegovy and Ozempic,⁣ have emerged as a transformative tool for many struggling with obesity. These⁣ medications mimic a natural hormone,suppressing appetite and promoting feelings of fullness. As science editor Ian Sample of the Guardian notes, the results have been⁤ remarkable, enabling users to achieve weight loss previously considered unattainable through diet and exercise alone.

The mechanism of action involves several key processes:

  • Appetite Suppression: GLP-1 agonists act on the brain to reduce‍ hunger and cravings.
  • Delayed Gastric Emptying: Food stays in the stomach ⁣longer, contributing to a feeling of fullness.
  • improved Insulin Sensitivity: These medications can also improve the body’s response to‍ insulin, which is beneficial for individuals with type 2 diabetes.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Keep reading

  • PAHO and AHF Launch Regional Alliance to Boost HIV Diagnosis and Treatment in Latin America
  • West Nile Virus Surge in Italy: Cases Rise in Rome and Prevention Tips

Related

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com